Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Katsumi Kubota is active.

Publication


Featured researches published by Katsumi Kubota.


Bioorganic & Medicinal Chemistry Letters | 2009

Synthesis and structure―activity relationships of phenothiazine carboxylic acids having pyrimidine-dione as novel histamine H1 antagonists

Katsumi Kubota; Hirotaka Kurebayashi; Hirotaka Miyachi; Masanori Tobe; Masako Onishi; Yoshiaki Isobe

A series of phenothiazine carboxylic acid derivatives, having 6-amino-pyrimidine-2,4(1H,3H)-dione moiety via a appropriate linker, were synthesized and evaluated for their affinity toward human histamine H(1) receptor and Caco-2 cell permeability. Selected compounds were further evaluated for their oral anti-histaminic activity in mice and bioavailability in rats. Finally, promising compounds were examined for their anti-inflammatory potential in mice OVA-induced biphasic cutaneous reaction model. Among the compounds tested, phenothiazineacetic acid compound 27 showed both histamine H(1)-receptor antagonistic activity and anti-inflammatory activity in vivo model.


Bioorganic & Medicinal Chemistry | 2011

Synthesis and structure–activity relationship of tricyclic carboxylic acids as novel anti-histamines

Katsumi Kubota; Hirotaka Kurebayashi; Hirotaka Miyachi; Masanori Tobe; Masako Onishi; Yoshiaki Isobe

A series of tricyclic carboxylic acids having 6-amino-pyrimidine-2,4(1H,3H)-dione with piperazino or homopiperazino moiety linked by propylene, were synthesized and evaluated for their affinity toward human histamine H(1) receptor and Caco-2 cell permeability. Selected compounds were further evaluated for their oral anti-histaminic activity in mice, bioavailability in rats, and their anti-inflammatory activity in mice OVA-induced biphasic cutaneous reaction model. Among the compounds tested, dibenzoxazepine carboxylic acid 13b showed both histamine H(1) receptor antagonistic activity and anti-inflammatory activity in vivo. In addition, 13b exhibited low affinity toward α(1) receptor and low occupancy of H(1) receptor in the brain. It is therefore, believed that 13b is a potential candidate for development as 3rd generation anti-histamine.


Bioorganic & Medicinal Chemistry | 2000

Synthesis and biological evaluations of A-ring isomers of 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3

Masahiko Ikeda; Kazuhiko Takahashi; Akihito Dan; Kohji Koyama; Katsumi Kubota; Tomoyuki Tanaka; Masaji Hayashi

The activated vitamin D3 derivative 26,27-F6-1alpha,25(OH)2D3 (2a), its three A-ring diastereomers (2b, 2c, 2d), and 5,6-trans isomer (2e) were prepared. Two analogues (2b, 2c) of these isomers were synthesized by a palladium catalyzed coupling reaction using vinyl bromide 5 and enynes (6a, 6b), which were derived from readily commercially available 2S-(+)-glycidyl p-toluenesulfonate 7, as a common starting material. Competitive vitamin D receptor (VDR) binding affinities of these diastereomers of 2a were evaluated. Interestingly, the stereochemical effects at C-1,3 of 2a were considerably more moderate than those of 1alpha,25(OH)2D3 (1). In particular, isomerization at the 5,6-double bond of 2a only slightly reduced VDR affinity, whereas 5,6-trans-1alpha,25(OH)2D3 had a significantly lower binding affinity than 1.


Proceedings of VII Microquasar Workshop: Microquasars and Beyond — PoS(MQW7) | 2009

Suzaku observations of SS 433 in the 2006 April multi-wavelength campaign

Katsumi Kubota; Yoshihiro Ueda; Taro Kotani; Nobuyuki Kawai; Masaaki Namiki; Kenzo Kinugasa; Sho Ozaki; Iijima Takashi; S. N. Fabrika

K. Kubota,a Y. Ueda,a T. Kotani,b N. Kawai,c M. Namiki,d K. Kinugasa,e S. Ozaki, f T. Iijimag and S. Fabrikah a Kyoto University, Japan b Aoyama Gakuin University, Japan c Tokyo Institute of Technology, Japan d Osaka University, Japan e Gunma Astronomical Observatory, Japan f Okayama Astrophysical Observatory, Japan g Astronomical Observatory of Padova, Italy h Special Astrophysical Observatory, Russia


The Journal of Antibiotics | 2002

New anti-MRSA and anti-VRE carbapenems; Synthesis and structure-activity relationships of 1β-metyl-2-(thiazol-2-ylthio)carbapenems

Makoto Sunagawa; Masanori Itoh; Katsumi Kubota; Akira Sasaki; Yutaka Ueda; Peter Angehrn; Anne Bourson; Erwin Goetschi; Paul Hebeisen; Rudolf L. Then


Archive | 2010

Novel fused pyrimidine derivative

Shigehiro Asano; 成宏 浅野; Katsumi Kubota; 久保田 克己; Mai Kasai; 舞 笠井; Yoshiaki Isobe; 磯部 義明


Archive | 1999

Novel beta-lactam compounds and process for producing the same

Makoto Sunagawa; Katsumi Kubota; Masanori Itoh; Erwin Goetschi


Archive | 2014

3-(aryl or heteroaryl) methyleneindolin-2-one derivatives as inhibitors of cancer stem cell pathway kinases for the treatment of cancer

Chiang Jia Li; Ji-Feng Liu; Wei Li; Amanda Gibeau; Harry Rogoff; Katsunori Tsuboi; Yosuke Takanashi; Shingo Tojo; Tomohiro Kodama; Katsumi Kubota; Toshio Kanai


Archive | 2014

HETEROCYCLIC SUBSTITUTED-3-HETEROARYLIDENYL-2-INDOLINONE DERIVATIVE

Katsunori Tsuboi; Yosuke Takanashi; Shingo Tojo; Tomohiro Kodama; Katsumi Kubota; Toshio Kanai


Archive | 2012

URACIL DERIVATIVE AND USE THEREOF FOR MEDICAL PURPOSES

Tomoya Shiro; Masanori Tobe; Katsumi Kubota; Yosuke Takanashi; Tomoaki Nakamura; Toshihiko Sone

Collaboration


Dive into the Katsumi Kubota's collaboration.

Top Co-Authors

Avatar

Makoto Sunagawa

Dainippon Sumitomo Pharma Co.

View shared research outputs
Top Co-Authors

Avatar

Masanori Itoh

Dainippon Sumitomo Pharma Co.

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yosuke Takanashi

Dainippon Sumitomo Pharma Co.

View shared research outputs
Top Co-Authors

Avatar

Masanori Tobe

Dainippon Sumitomo Pharma Co.

View shared research outputs
Top Co-Authors

Avatar

Tomoya Shiro

Dainippon Sumitomo Pharma Co.

View shared research outputs
Top Co-Authors

Avatar

Hirotaka Kurebayashi

Dainippon Sumitomo Pharma Co.

View shared research outputs
Top Co-Authors

Avatar

Hirotaka Miyachi

Dainippon Sumitomo Pharma Co.

View shared research outputs
Top Co-Authors

Avatar

Masako Onishi

Dainippon Sumitomo Pharma Co.

View shared research outputs
Researchain Logo
Decentralizing Knowledge